Abstract
Background: There is an increased interest in ‘late-onset’ attention-deficit/hyperactivity disorder (ADHD), referring to the onset of clinically significant ADHD symptoms after the age of 12 years. This study aimed to examine whether unaffected siblings with late-onset ADHD could be differentiated from stable unaffected siblings by their neurocognitive functioning in childhood. Methods: We report findings from a 6-year prospective, longitudinal study of the Dutch part of the International Multicenter ADHD Genetics (IMAGE) study, including individuals with childhood-onset (persistent) ADHD (n = 193), their siblings with late-onset ADHD (n = 34), their stable unaffected siblings (n = 111) and healthy controls (n = 186). At study entry (mean age: 11.3) and follow-up (mean age: 17.01), participants were assessed for ADHD by structured psychiatric interviews and multi-informant questionnaires. Several neurocognitive functions were assessed at baseline and after 6 years, including time reproduction, timing variability (reaction time variability and time production variability), reaction time speed, motor control and working memory; intelligence was taken as a measure of overall neurocognitive functioning. Results: Siblings with late-onset ADHD were similar to individuals with childhood-onset ADHD in showing longer reaction times and/or higher error rates on all neurocognitive measures at baseline and follow-up, when compared to healthy controls. They differed from stable unaffected siblings (who were similar to healthy controls) by greater reaction time variability and timing production variability at baseline. No significant group by time interaction was found for any of the tasks. Conclusions: For unaffected siblings of individuals with ADHD, reaction time variability and timing production variability may serve as neurocognitive marker for late-onset ADHD.
| Original language | English |
|---|---|
| Pages (from-to) | 244-252 |
| Number of pages | 9 |
| Journal | Journal of Child Psychology and Psychiatry and Allied Disciplines |
| Volume | 62 |
| Issue number | 2 |
| Early online date | 12 Jul 2020 |
| DOIs | |
| Publication status | Published - Feb 2021 |
Bibliographical note
Publisher Copyright:© 2020 Association for Child and Adolescent Mental Health
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
Funding
This work was supported by National Institute of Health (NIH) Grant R01MH62873, the Netherlands Organization for Scientific Research (NWO) Large Investment Grant 1750102007010, ZonMW Grant 60‐60600‐97‐193 and grants from Radboud University Medical Center, University Medical Center Groningen and Accare, and VU University Amsterdam. B.F. is supported by a Vici grant (016.130.669) from NWO, and she and J.K.B. received funding from the European Commission Framework 7 Program under grant number 602450 (IMAGEMEND). This work was supported by National Institute of Health (NIH) Grant R01MH62873, the Netherlands Organization for Scientific Research (NWO) Large Investment Grant 1750102007010, ZonMW Grant 60-60600-97-193 and grants from Radboud University Medical Center, University Medical Center Groningen and Accare, and VU University Amsterdam. B.F. is supported by a Vici grant (016.130.669) from NWO, and she and J.K.B. received funding from the European Commission Framework 7 Program under grant number 602450 (IMAGEMEND). All participants gave informed consent, and the study was approved by ethical committees of University Medical Centre Utrecht and Arnhem-Nijmegen. Reference numbers are as follows: 97/268, 2008/163 and 2012/542. The authors thank all the families and teachers who took part in this study and all students for their assistance in data collection. This study was presented as an oral presentation at the 7th World Congress on ADHD, Lisbon, Portugal, 27 April 2019. J.K.B. has been in the past 3?years a consultant to / member of advisory board of / and/or speaker for Janssen Cilag BV, Eli Lilly, Lundbeck, Shire, Roche, Medice, Novartis and Servier. He has received research support from Roche and Vifor. J.K.B. has been in the past 3 years a consultant to / member of advisory board of / and/or speaker for Janssen Cilag BV, Eli Lilly, Lundbeck, Shire, Roche, Medice, Novartis and Servier. He has received research support from Roche and Vifor. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents and royalties. P.J.H. has been paid member of an advisory board of Takeda. B.F.’s work is supported by a personal Vici grant from the Netherlands Organization for Scientific Research (NWO; grant 016‐130‐669). The remaining authors have declared that they have no competing or potential conflicts of interests. Key points
| Funders | Funder number |
|---|---|
| National Institutes of Health | |
| European Commission | |
| Vifor | |
| Vrije Universiteit Amsterdam | |
| University Medical Centre Utrecht | |
| Roche | |
| Seventh Framework Programme | 602450 |
| Arnhem-Nijmegen | 97/268, 2012/542, 2008/163 |
| Nederlandse Organisatie voor Wetenschappelijk Onderzoek | 1750102007010, 016.130.669 |
| National Institute of Mental Health | R01MH062873 |
| ZonMw | 60‐60600‐97‐193 |
Keywords
- Late-onset ADHD
- neurocognitive markers
- unaffected siblings
Fingerprint
Dive into the research topics of 'Neurocognitive markers of late-onset ADHD: a 6-year longitudinal study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver